Sight Sciences, Inc.
SGHT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001531177
In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 6 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Sight Sciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 56 | 60 | +4 |
| Shares | 18.5M | 23.8M | +5.26M (+28.4%) |
| Value | $419.0M | $416.6M | −$2.40M (−0.6%) |
New holders (20)
Institutions that held Sight Sciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| KCK Ltd. | 4,776,232 | $83.9M | 59.26% |
| Sectoral Asset Management Inc | 170,000 | $2.99M | 0.45% |
| Magnetar Financial LLC | 149,806 | $2.63M | 0.03% |
| HRT Financial LP | 79,414 | $1.40M | 0.01% |
| Cinctive Capital Management LP | 77,000 | $1.35M | 0.06% |
| Crestline Management, LP | 56,811 | $998.0K | 0.07% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 53,417 | $956.0K | 0.00% |
| Renaissance Technologies LLC | 49,400 | $868.0K | 0.00% |
| Tudor Investment Corp Et Al | 46,359 | $815.0K | 0.02% |
| Gyon Technologies Capital Management, LP | 32,555 | $572.0K | 0.11% |
| Swiss National Bank | 26,100 | $459.0K | 0.00% |
| Parametric Portfolio Associates LLC | 23,892 | $420.0K | 0.00% |
| Boothbay Fund Management, LLC | 23,397 | $411.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 17,532 | $308.0K | 0.00% |
| M&T Bank Corp | 13,048 | $229.0K | 0.00% |
| Paloma Partners Management Co | 11,986 | $211.0K | 0.01% |
| New York State Common Retirement Fund | 7,097 | $125.0K | 0.00% |
| UBS Group AG | 3,840 | $67.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 97 | $2.00K | 0.00% |
| Marshall Wace, LLP | 100 | $1.00K | 0.00% |
Sold out (16)
Institutions that held Sight Sciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| PFM Health Sciences, LP | 483,538 | $11.0M |
| FMR LLC | 274,400 | $6.23M |
| Avidity Partners Management LP | 145,189 | $3.30M |
| Caas Capital Management LP | 85,000 | $1.93M |
| UBS Asset Management Americas Inc | 82,589 | $1.87M |
| Point72 Asset Management, L.P. | 48,400 | $1.10M |
| Rokos Capital Management LLP | 40,000 | $910.0K |
| Jennison Associates LLC | 38,733 | $879.0K |
| Goldman Sachs Group Inc | 37,728 | $856.0K |
| Davidson Kempner Capital Management LP | 27,000 | $609.0K |
| Moore Capital Management, LP | 23,653 | $537.0K |
| Cubist Systematic Strategies, LLC | 20,159 | $458.0K |
| D. E. Shaw & Co., Inc. | 18,828 | $427.0K |
| Two Sigma Investments, LP | 10,138 | $230.0K |
| MetLife Investment Management | 4,737 | $107.5K |
| Metropolitan Life Insurance Co | 3,584 | $81.4K |